A foreign body is any abnormal substance or object that does not belong to the body (eye). The incidence of foreign body in the eye is high especially in the industrial towns. It can occur at any age and in both genders. It affects the eye by mechanical effects, by introduction of infection or by specific reaction. Introduction of a foreign body is a significant disturbance and can create health problem. The study of the foreign body presents unparalleled opportunities for reducing morbidity and for realizing significant savings in both financial and human terms.
Showing posts with label clinical experimental ophthalmology impact factor. Show all posts
Showing posts with label clinical experimental ophthalmology impact factor. Show all posts
Friday, 30 June 2017
Monday, 22 May 2017
Corneal Toxicity after Self-Application of Calotropis procera (Ushaar) Latex: Case Report and Analysis of the Active Components
Calotropis
procera (ushaar) produces a copious amount of latex, which has both
inflammatory and antiinflammatory pharmacological properties. Local application
produces an intense inflammatory response and causes significant ocular
morbidity.
We report corneal toxicity following self-application of latex from
C. procera in a 74-yearold man. He reported painless decreased vision in the affected eye with diffuse corneal edema, and specular microscopy revealed a reduced endothelial cell count. After he was treated with topical
corticosteroids, his visual acuity improved from HM to 20/80. The composition
of the active compounds in the latex was analyzed. When topically administered,
the latex may cause severe ocular injuries and a loss of endothelial cells over
a period of time. Public education, early recognition of such injuries, and
timely intervention may prevent permanent ocular damage
Thursday, 18 May 2017
Maculopathy associated with Prior Tamoxifen Use Diagnosed with Commercially Available Fourier-Domain Optical Coherence Tomography: A Case Series
Tamoxifen is a drug used to treat
estrogen receptor positive breast cancer that can induce retinopathy. The diagnosis of tamoxifen retinopathy is traditionally established by macularedema seen on fluorescein angiography and retinal crystalline deposits seen on funduscopy. Macular edema associated with tamoxifen retinopathy has been
reported to be reversible after cessation of the drug but the retinal crystalline
opacities usually persist.
Recently, a case of bilateral microcystoid
maculopathy with patches of photoreceptor loss associated with concurrent
tamoxifen use was detected using a research-grade high resolution
Fourier-domain optical coherence tomography (Fd-OCT) in a patient with vision
loss unexplained by funduscopy, fluorescein angiogram (FA), multifocal electro retinography and Stratus OCT. This report describes two new cases of maculopathy associated
with prior tamoxifen use in which similar morphologic changes were seen using
commercially available Fd-OCTs, Cirrus (Carl Zeiss Meditec, Dublin, CA) and
RTVue (Optovue, Fremont, CA), in eyes that appeared unremarkable on funduscopy.
Thursday, 11 May 2017
Management of Corneal Graft Rejection - A Case Series Report and Review of the Literature
To report long-term results in a
case series of patients treated with systemic immune suppression for prevention
of penetrating keratoplasty (PKP) graft rejection. Retrospective non comparative
chart review. Three patients presented with PKP graft failure.
Patients received oral prednisone, azathioprine and cyclosporine to
prevent rejection of repeat corneal transplant. Patients received repeat PKPand graft outcome was reported. Main outcome measures: Visual acuity and graft
survival were recorded. Mean age was 55 years, two male and one
female. Mean follow-up period was 37 months (range 24- 46). All three patients
completed the treatment protocol with minimal adverse effects. All grafts
remained clear over observational period. Conclusion: Our study suggests that
systemic immune suppression with 2 or more agents may be helpful to prevent
corneal graft rejection in high-risk patients.
Tuesday, 18 April 2017
Combined Antifungal therapy is effective in handling fungal keratitis
Fungal keratitis is an alarming
disease with a significant impact on the vision quality. Although anti fungal drugs are effective in controlling this disorder, a significant challenge lies
in the management of the disease.
The drug delivery into the corneal tissues
and identification of fungal pathogens play important roles in management of
fungal keratitis. Although 10 different varieties of antibacterial, antifungal
and cycloplegic drugs are available, a combined therapy of antifungal agents
achieved the best treatment modality in cases of fungal keratitis.
Friday, 30 December 2016
Retreatment Rate Following Supracor Treatment of Hyperopic Presbyopia
To report the retreatment rate and
safety of presbyopia treatment using the corneal laser in situ keratomileusis
(LASIK) procedure, Supracor. In this case series, bilateral LASIK using the Supracor algorithm was performed on consecutive hyperopic presbyopic patients.
All patients were followed for a minimum of six months postoperatively. The principal outcome measures were re treatment rate, safety, efficacy in terms of
uncorrected distance visual acuity (UDVA) and uncorrected reading ability (vocational
reading test), patient satisfaction, stability and predictability. Results: 76
eyes of 38 patients were treated. 42% of patients (16 patients) that were
treated required at least one re-treatment.
Monday, 26 December 2016
Epidermal Cyst of Upper Eyelid: A Case Report with Literature Review
Epidermal cysts are benign slow
growing tumors resulting from proliferation of epidermal cells. Usually cysts
are asymptomatic; however, they may become inflamed or secondarily infected.
Epidermal cysts are solitary sub epithelial cysts, are slowly progressive and firm in consistency. They are most commonly seen on the face, scalp, neck and
trunk. Epidermoid cysts are frequently seen on the upper eyelid, mainly on the
conjunctiva or on the skin. This may be misdiagnosed as chalazion or sebaceous
cyst. Surgical excision of the cyst in toto is the treatment of choice or else
there will be recurrence, granulomatous reaction or foreign body reaction.
Monday, 31 October 2016
Automatic Measurement of Choroidal Thickness with Swept-Source Optical Coherence Tomography for Clinical Follow-Up in Acute Vogt-Koyanagi-Harada Disease
Vogt-Koyanagi-Harada
(VKH) syndrome is a bilateral granulomatous uveitis that typically presents
with distinct clinical features based on the duration and stage of the disease.
The acute stage of VKH is characterized by diffuse choroiditis, multifocal
areas of subretinal fluid and/or bullous serous retinal detachments, with or
without neurologic (headaches, meningismus) or auditory (tinnitus, hypoacusia)
symptoms.
The convalescent stage of the disease develops 12 weeks after onset
and is characterized by resolution of retinal detachments with disappearance of
cells from the anterior chamber and the vitreous, with characteristic
pigmentary changes in the macula and sunset glow fundus. The chronic/recurrent
phase is characterized by clinical signs of disease activity in the anterior
segment of the eye with anterior granulomatous uveitis and dermatologic signs
(vitiligo, alopecia, poliosis).
Monday, 10 October 2016
Prologue to the Special Issue: Age-Related Macular Degeneration
Age-related macular degeneration
(AMD) is a leading cause of irreversible vision loss among people age 50 and
older. Based on the presence or absence of blood vessels, it is classified intotwo types, wet and dry. In the past decades, significant progress has been made
in understanding the molecular mechanisms underlying wet AMD, and several
robust therapeutic drugs were developed to block the development of new blood
vessels and leakage from the abnormal vessels with favorable clinical effect.
In
contrast, there are no approved treatments for dry AMD and the mechanisms are
not completely known. However, it has been approved that genetics, complement
dysregulation, oxidative stress, mitochondria DNA damage were involved in the mechanisms. Variety of scientific studies, including gene replacement therapy,
retinal cell transplantation, pharmaceutical intervention and vitamin dietary
supplementation, hold promise in developing treatment to prevent or slow the
progression of the disease. In the clinical aspect, multiple clinical studies
and trials have been done to further our knowledge of AMD, and on-going studies
are raising hopes for improved treatments.
Monday, 26 September 2016
Neuronavigational Approach for Orbital Neurofibroma Excision: A Case Report
Orbital neurofibromas are uncommon
in adults, accounting for approximately 1%-3% of all space occupying lesions of
the orbit. The complex anatomy of the orbital region, with the pronounced
vulnerability of its neurovascular structures, requires particular surgical
precautions. Neuronavigation, as a high-tech device for intraoperative safety,represents a valuable option for the confined orbital space. However, the
application of neuronavigation in orbital surgery has been rarely reported. The
authors present a case report of a 32-year-old female with an isolated
localized neurofibroma surgically approached by intraoperative navigation and a
review of the literature.
A 32-year-old female presented with
a 2-year history of left upper lid swelling and progressive onset of proptosis
and double vision (Figure 1). She had no family history of neurofibromatosis.
Ophthalmologist’s examinationrevealed a decreased visual acuity 7/10 associated with ptosis, unilateral
exophthalmos with restricted eyeball movement on upward and lateral gaze in the
left eye. The visual field examination was normal.
Subscribe to:
Posts (Atom)









